新宙邦(300037.SZ):擬設立控股子公司浙江新宙邦 以投建年產10萬噸電池電解液項目
格隆匯3月27日丨新宙邦(300037.SZ)公佈,公司擬以控股子公司浙江新宙邦材料有限公司(暫定名,以工商註冊登記為準,簡稱“浙江新宙邦”或“合資公司”)為項目實施主體,擬投資建設年產10萬噸電池電解液項目,項目預計投資人民幣4億元,項目分兩期實施,其中一期建設5萬噸電池電解液,二期5萬噸電池電解液視市場情況啟動建設。
浙江新宙邦由公司與永青科技股份有限公司(簡稱“永青科技”)、格林美股份有限公司(簡稱“格林美”)、浙江偉明環保股份有限公司(簡稱“偉明環保”)共同出資人民幣 1.2億元設立,其中,新宙邦以現金出資8160萬元,佔註冊資本的68%;永青科技以現金出資2400萬元,佔註冊資本的20%;格林美以現金出資720萬元,佔註冊資本的6%;偉明環保以現金出資720萬元,佔註冊資本的6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.